YIELD10 BIOSCI Revenue, Profits - YTEN Quarterly Income Statement

Add to My Stocks
$2.48 $0.15 (6.27%) YTEN stock closing price Aug 22, 2017 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the YIELD10 BIOSCI stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from $0.32M to $0.29M and how operating and non operating activities have impacted the YTEN stock. Along with YIELD10 BIOSCI assets and YIELD10 BIOSCI free cash flow, profits as shown in profit and loss statement give key insights about the business. The profits have decreased from $-2.09M QoQ and 2017-Q2 revenue is $0.29M. View details of revenue and profits for YIELD10 BIOSCI for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec.2017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q1
YIELD10 BIOSCI Net Sales or Revenues
0.29M0.32M0.34M0.47M2.79M0.68M0.5M0.71M0.74M0.65M
Cost Of Goods Sold (COGS)---0.23M-0.12M0.11M0.15M0.34M0.09M0.08M
YIELD10 BIOSCI Gross Profit
0.29M0.32M-2.54M0.47M2.67M0.55M0.36M0.36M0.65M0.56M
Research & Development Expense1.14M1.1M-4.48M1.54M4.28M4.33M4.26M4.08M4.31M3.92M
Selling General & Admin Expense1.87M1.27M-0.13M1.53M1.61M2.72M2.03M2.15M2.46M2.46M
Income Before Depreciation Depletion Amortization-2.71M-2.06M2.09M-2.6M-3.23M-6.5M-5.91M-5.88M-6.12M-5.83M
Depreciation Depletion Amortization----------
Non Operating Income-0.02M-0.03M-0.06M-0.01M0.03M--0.01M0.03M0.05M-0.01M
Interest Expense----------
YIELD10 BIOSCI Pretax Income
-2.73M-2.09M2.01M-2.61M-3.19M-6.49M-5.93M-5.84M-6.07M-5.84M
Provision for Income Taxes---0.05M-1.04M------
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-2.73M-2.09M-1.57M-1.49M-3.2M-6.5M-5.92M-5.85M-6.07M-5.84M
Extraordinary Items & Discontinued Operations---0.36M5.51M------
YIELD10 BIOSCI Net Income (Profit/Loss)
-2.73M-2.09M-1.93M4.02M-3.2M-6.5M-5.92M-5.85M-6.07M-5.84M
Average Shares used to compute Diluted EPS2.85M2.84M2.83M2.79M2.77M2.74M2.73M2.7M2.31M2.26M
Average Shares used to compute Basic EPS2.85M2.84M2.83M2.79M2.77M2.74M2.73M2.7M2.31M2.26M
Income Before Nonrecurring Items-2.73M-2.09M-1.57M-1.49M-3.2M-6.5M-5.92M-5.85M-6.07M-5.84M
Income from Nonrecurring Items----------
YIELD10 BIOSCI Earnings Per Share Basic Net
-0.96-0.70-0.701.40-1.20-2.40-2.20-2.20-2.60-2.40
YIELD10 BIOSCI Earnings Per Share Diluted Net
-0.96-0.70-0.701.40-1.20-2.40-2.20-2.20-2.60-2.40
EPS Diluted Before Nonrecurring Items-0.96-0.70-0.60-0.50-1.20-2.40-2.20-2.20-2.60-2.40
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

Before investing one should read a report on YIELD10 BIOSCI stock analysis. It helps to look at the following income statement items:
  • Topline: A growing topline, as seen from the YIELD10 BIOSCI revenue chart, as is not the case with YIELD10 BIOSCI indicates a sagging business. One needs to compare the QoQ or YoY topline growth of YTEN stock with its peers like RIBT stock and YEWB stock to see if the growth compares well with what can be expected for a company in that industry.
  • Bottom line: Most businesses like YIELD10 BIOSCI try to improve their bottom line by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.
The income statement is also called statement of revenue and expense. The financials along with YIELD10 BIOSCI historical stock prices provides a lot of details about the firm. .

YIELD10 BIOSCI Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
)
4.9694
Operating margin
-643.8
Net profit margin
-653.1
Dividend yield
0%

Other Income Statements - YIELD10 BIOSCI Industry Peers

Honeywell income statement, Ricebran income statement, Yew Bio Pharm income statement